On-site Governance Standards for Cement Enterprises (Trial)
Release time:
2021-10-21
News from our newspaper 10# February 15 , the group company issued the "Cement Enterprise Site Management Standard (Trial)", which will be implemented in three cement enterprises on 11# June 1 . This is the company's first innovative document on site governance.
On-site standardization is an important work deployed by the group company to promote technological progress, safe and civilized production. After the procedures of project proposal, project establishment, organization and drafting, soliciting opinions, repeated discussion and revision, technical review and other procedures, the "Cement Enterprise Site Governance Standard (Trial)" has been approved and issued by the Group Company, and will become the normative document guiding all cement enterprises to carry out site governance and upgrade and reform to meet the standards in the next stage."Cement Enterprise Site Governance Standards (Trial)" clearly stipulates the main site governance standards of cement enterprises and the main contents that need to meet the standards, and clarifies the basic requirements for each site link in the three-year action plan for site governance. The "site" includes not only all facilities and equipment of the production line, but also the gate, factory roads, office buildings and living areas. The "contents that need to meet the standards" include not only fixed location management and site hygiene, but also clearly stipulate the color of the building appearance and facilities and equipment, the marking of ground functions, the marking methods of various signs and signs, etc., basically covering all places within the factory area of cement enterprises.
It is understood that since the "Cement Enterprise Site Governance Standard (Trial)" is the company's first innovative document on site governance, the regulations for site details need to be further improved. The company requires all cement companies to be specific During the implementation process, suggestions are made according to the actual situation. The company will also organize a standard revision once a year, and strive to achieve major changes in the cement enterprise site through three years of hard work, and make the trial standard an advanced, comprehensive and replicable enterprise standard.
Although this on-site governance standard is only for cement companies, the text of the standard is also distributed to pharmaceutical companies and other directly affiliated companies. The company requires pharmaceutical companies and other directly affiliated enterprises to refer to the on-site governance standards of cement enterprises, organize the preparation of on-site governance standards according to the actual situation of the enterprise, complete the first draft before the end of
11 , report it to the company's audit performance management department for examination and confirmation, and issue it for implementation before the new year's day of 2022 . (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31